These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 28011392)

  • 1. Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model.
    Chan GN; Evans RA; Banks DB; Mesev EV; Miller DS; Cannon RE
    Neurosci Lett; 2017 Feb; 639():103-113. PubMed ID: 28011392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.
    Qosa H; Lichter J; Sarlo M; Markandaiah SS; McAvoy K; Richard JP; Jablonski MR; Maragakis NJ; Pasinelli P; Trotti D
    Glia; 2016 Aug; 64(8):1298-313. PubMed ID: 27158936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.
    Jablonski MR; Jacob DA; Campos C; Miller DS; Maragakis NJ; Pasinelli P; Trotti D
    Neurobiol Dis; 2012 Aug; 47(2):194-200. PubMed ID: 22521463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excess glutamate secreted from astrocytes drives upregulation of P-glycoprotein in endothelial cells in amyotrophic lateral sclerosis.
    Mohamed LA; Markandaiah SS; Bonanno S; Pasinelli P; Trotti D
    Exp Neurol; 2019 Jun; 316():27-38. PubMed ID: 30974102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and Cellular Distribution of P-Glycoprotein and Breast Cancer Resistance Protein in Amyotrophic Lateral Sclerosis Patients.
    van Vliet EA; Iyer AM; Mesarosova L; Çolakoglu H; Anink JJ; van Tellingen O; Maragakis NJ; Shefner J; Bunt T; Aronica E
    J Neuropathol Exp Neurol; 2020 Mar; 79(3):266-276. PubMed ID: 31999342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive androstane receptor-mediated up-regulation of ATP-driven xenobiotic efflux transporters at the blood-brain barrier.
    Wang X; Sykes DB; Miller DS
    Mol Pharmacol; 2010 Sep; 78(3):376-83. PubMed ID: 20547735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of GenX on P-Glycoprotein, Breast Cancer Resistance Protein, and Multidrug Resistance-Associated Protein 2 at the Blood-Brain Barrier.
    Cannon RE; Richards AC; Trexler AW; Juberg CT; Sinha B; Knudsen GA; Birnbaum LS
    Environ Health Perspect; 2020 Mar; 128(3):37002. PubMed ID: 32212926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P-glycoprotein expression and function are increased in an animal model of amyotrophic lateral sclerosis.
    Milane A; Fernandez C; Dupuis L; Buyse M; Loeffler JP; Farinotti R; Meininger V; Bensimon G
    Neurosci Lett; 2010 Mar; 472(3):166-70. PubMed ID: 20138122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 upregulates ATP binding cassette transporter expression and activity at the blood-brain and blood-spinal cord barriers.
    Wang X; Campos CR; Peart JC; Smith LK; Boni JL; Cannon RE; Miller DS
    J Neurosci; 2014 Jun; 34(25):8585-93. PubMed ID: 24948812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central Nervous System Distribution of Panobinostat in Preclinical Models to Guide Dosing for Pediatric Brain Tumors.
    Zhang W; Oh JH; Zhang W; Rathi S; Larson JD; Wechsler-Reya RJ; Sirianni RW; Elmquist WF
    J Pharmacol Exp Ther; 2023 Dec; 387(3):315-327. PubMed ID: 37827699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P-glycoprotein mediated efflux limits the transport of the novel anti-Parkinson's disease candidate drug FLZ across the physiological and PD pathological in vitro BBB models.
    Liu Q; Hou J; Chen X; Liu G; Zhang D; Sun H; Zhang J
    PLoS One; 2014; 9(7):e102442. PubMed ID: 25036090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility of juvenile and adult blood-brain barrier to endothelin-1: regulation of P-glycoprotein and breast cancer resistance protein expression and transport activity.
    Harati R; Villégier AS; Banks WA; Mabondzo A
    J Neuroinflammation; 2012 Dec; 9():273. PubMed ID: 23253775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Human Breast Cancer Related Protein versus P-Glycoprotein as an Efflux Transporter for Benzylpenicillin: Potential Importance at the Blood-Brain Barrier.
    Li Y; Wu Q; Li C; Liu L; Du K; Shen J; Wu Y; Zhao X; Zhao M; Bao L; Gao J; Keep RF; Xiang J
    PLoS One; 2016; 11(6):e0157576. PubMed ID: 27300692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis.
    Jablonski M; Miller DS; Pasinelli P; Trotti D
    Brain Res; 2015 May; 1607():1-14. PubMed ID: 25175835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and ex vivo regulation of breast cancer resistant protein (Bcrp) by peroxisome proliferator-activated receptor alpha (Pparα) at the blood-brain barrier.
    Hoque MT; Shah A; More V; Miller DS; Bendayan R
    J Neurochem; 2015 Dec; 135(6):1113-22. PubMed ID: 26465636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood-Brain Barrier Driven Pharmacoresistance in Amyotrophic Lateral Sclerosis and Challenges for Effective Drug Therapies.
    Mohamed LA; Markandaiah S; Bonanno S; Pasinelli P; Trotti D
    AAPS J; 2017 Nov; 19(6):1600-1614. PubMed ID: 28779378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of P-glycoprotein and multidrug resistance associated protein 1 in the transport of tanshinone IIB, a primary active diterpenoid quinone from the roots of Salvia miltiorrhiza, across the blood-brain barrier.
    Zhou ZW; Chen X; Liang J; Yu XY; Wen JY; Zhou SF
    Drug Metab Lett; 2007 Aug; 1(3):205-17. PubMed ID: 19356045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered blood-brain barrier and blood-spinal cord barrier dynamics in amyotrophic lateral sclerosis: Impact on medication efficacy and safety.
    Pan Y; Nicolazzo JA
    Br J Pharmacol; 2022 Jun; 179(11):2577-2588. PubMed ID: 35048358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABC transporter regulation by signaling at the blood-brain barrier: relevance to pharmacology.
    Miller DS
    Adv Pharmacol; 2014; 71():1-24. PubMed ID: 25307212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting drug efflux transporters improves efficacy of ALS therapeutics.
    Jablonski MR; Markandaiah SS; Jacob D; Meng NJ; Li K; Gennaro V; Lepore AC; Trotti D; Pasinelli P
    Ann Clin Transl Neurol; 2014 Dec; 1(12):996-1005. PubMed ID: 25574474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.